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ABSTRACT 
Papillomaviruses are a genera of small tumor viruses in the Papovaviridae 
family, whose lifecycle and replication ability is directed by epithelial differentiation. 
During latency, papillomavirus DNA replication occurs synchronously with the host 
cell's replication by the activation of the El protein. To elucidate the effects upon viral 
replication, this study utilized chemical inhibition of several kinases predicted to 
phosphorylate, and subsequently modify the activity of, the papilloma virus' E 1 protein. 
The amount of DNA replicated was observed via autoradiography following DNA 
extraction and southern blotting ofBPV-transformed C127 cells. Sample extracts from 
cells exposed to specific chemical inhibitors of PKC, CDK, and DNAPK showed a 
consistent and significant decrease in viral DNA when compared to the DNA abundance 
of a control set of extracts. Extracts of cells subjected to inhibition of CK2 displayed an 
observable increase in replicated viral DNA. To ensure that the kinase modification was 
not effecting the growth or viability of the cells, a neutral red assay was performed and 
found no significant difference between control and chemically treated samples in cell 
viability or overall cell number. These findings, in conjunction with the differential viral 
DNA abundance, implicate that kinases PKC, CDK, CK2, and DNAPK, have a role in 
viral genome replication. 
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I~TRODl_JCTION 
Papillomavimses are small (capsid, 55-nm; genome, 8 kbp) obligate 
intracellular parasites that infect epithelial cells of the skin and mucous membranes in a 
range ofvertebrate hosts [1-5, 6, 10]. These double-stranded DNA tumor viruses are one 
of the two genera within the Papovaviridae family and the non-enveloped virions exhibit 
T=7 icosahedral symmehy [28, 30]. Entry ofvims particles occurs via abrasive 
mechanism, which exposes the target basal cell layer. This exposure is followed by 
clathrin-dependent endocytosis and nucleocapsid L2 protein-mediated egress from late 
endosomes into cell cytoplasm [31 ]. The papillomavims has a complex lifecycle which is 
closely linked to the differentiation status of the epithelial cells. During latency 
papillomavims DNA replication can only occur during the host cellS-phase of the cell 
cycle [7, 10, 17, 24]. Following viral attachment, entry, and nucleocapsid disassembly, 
initial infection and viral latency are characterized by low viral genome copy number 
(50-200 per cell) and minimal gene expression, where only a select few genes are 
transcribed in low concentration. The viral genome exists as an extra-chromosomal 
episome and remains perpetually present in the stratum basale layer, allowing for the 
vims's persistent ability to relapse [32]. Papillomavimses are non-lytic, and mature 
virions are shed only as the stratum corneum desquamates. 
These vimses primarily infect the basal layer, or stratum basale, of stratified 
squamous (both keratinizing and non-keratinizing) epithelial tissue. The stratum basale 
cells, found just superficial to the dermis, are often characterized as the skin "stem cells," 
as they are the only layer of cells that undergo mitosis and subsequently the only layer in 
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which DNA is replicated. These vimses are termed oncogenic because they transform the 
infected cells in their efforts to maintain replicative status in the cell, producing 
unregulated cellular growth. As the infected cells divide and proliferate outward the virus 
triggers a hyperproliferation of nearby keratinocytes and benign skin tumors (warts), or 
papillomas, are often produced [ 10, 25]. These warts are most often manifested in the 
skin of the host's outer extremities, but specific strains of the papillomavirus regularly 
arise in the mucosa [8, 10]. These neoplasms are not typically life threatening for the 
host, but if the viral cycle does not regress or the host is exposed to environmental 
carcinogens, they may become malignant and metastasize to other locations in the body. 
Certain "high-risk" papilloma virus strains, those that readily induce modifications 
allowing for immortalization, are more known to develop into malignant cancers, while 
those of "low-risk" are rarely linked to malignancy [1 0, 17]. 
The viral genome contains three basic regions, each characterized by their relative 
functions. The first region consists of an upstream regulatory domain, containing 
sequences that control transcription and replication. This sequence is followed by a 
region containing many of the genes involved in the actual viral replication, transcription, 
and transformation, the early domain; and a structural region, the late domain [7, 11, 24-
26]. The early region encodes for the early proteins, El-E8, and the late contains two 
genes; L 1, which forms the viral capsid and L2, a minor capsid component, which is also 
responsible for viral DNA packaging. Translation of the late proteins is necessary for the 
progeny virons to be able to evacuate the host cell and proliferate the infection cycle. 
This stage in the lifecycle only occurs in the outer epithelial layers (outer stratum 
spinosum and stratum granulosum), those most highly differentiated [12, 13, 17]. 
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Like all DNA tumor vimses, the papillomavirus uses host cell proteins for their 
own DNA replication. They do, however, encode for a specific replication origin ( ori) 
binding and viral DNA unwinding molecule: the E1 protein [1-5, 7, 8]. The E1 protein, 
which is a 593-681 amino acid polypeptide (approximately 67.5-76.2 kDa depending on 
the viral strain), has the largest and most sequentially conserved open reading frame in 
the viral genome [7]. For the virus to replicate conectly, the a- helix rich El protein 
forms a hexameric or double-hexameric complex, facilitated by the activity of a heat-
shock chaperone protein [12]. E1 contains binding domains for DNA, ATP, and the E2 
protein, an auxiliary origin recognition protein. When E1 and E2 are coupled together, 
the complex, via its loop-helix motif, will locate and attach to the origin replication site 
of the viral genome. While the presence of E2 in the complex is not altogether necessmy, 
the sequence specific recognition ability of E 1 is enhanced when E2 is present in the pre-
replication complex [7, 12]. Once bound to the origin, El causes the initial unwinding of 
viral DNA at the replication fork through its 3' -7 5' helicase activity. Unwinding is an 
ATP dependent process, which hydrolyses the ATP bound at the P-loop of the protein at 
a rate of one molecule per round of activity [7, 12, 14]. This activity occurs at the 
carboxy-terminal domain. This model has been demonstrated by studies with amino-
terminus deleted E 1 where the tmncated protein still maintains replication functionality, 
albeit at a slower rate of viral DNA unwinding [1, 2, 7]. Strain comparison studies have 
revealed that the carboxy-terminal domain is the most highly conserved section of the 
protein's sequence [7]. 
E 1 is the only papillomavims protein with enzymatic function, which it must 
employ to unwind the viral template DNA. In the presence of unwound template the 
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protein must then recruit the cellular replication machinery to the viral DNA. Following 
recruitment, it is then up to the infected cell to complete replication. Given the virus' 
compact genome, most of the components needed for viral reproduction are not encoded 
for by the viral DNA, and so all other factors necessary for replication must be supplied 
by the host cell. The E1 protein has been shown to be responsible for soliciting host cell 
DNA polymerases (a and 8), replication protein A (RP A), proliferating cell nuclear 
antigen (PCNA), and topoisomerases [13, 14, 23]. The success ofE1 's ability to bind to 
all of the required replication elements, within the proper time frame, suggests a 
significant level of regulation of E 1 's multiple binding sites [7, 20]. Data has 
demonstrated that the viral replication protein E1 may have the potential to influence the 
host cell environment significantly, instead of waiting idly in a latent stage. Expression of 
E 1 protein has been shown to decrease the duration of G 1 phase and increase S phase, 
allowing for maximal viral DNA replication and may contribute to the virus' 
pathogenesis and persistence within the host cell [9, 1 0]. 
Unique to the papilloma virus is its ability to direct the activation of its DNA 
replication to occur synchronously with the host cell's replication [7, 10, 17]. The timing 
of this activation and subsequent stimulation of the E1 protein is critical for viral 
replication and therefore, exhibits differential regulation sites specific for timing and 
utilization of the viral genomic replication. Without the presence of a complex cell cycle 
regulation system of its own, the virus depends largely upon the phosphorylation ofE1 
protein to regulate viral DNA replication during host cell S-phase [7 -14, 25]. This fact 
also makes the papillomavirus an excellent model system for studying some aspects of 
eukaryotic DNA replication mechanisms [1-5, 17]. 
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Protein phosphorylation is a common regulatory mechanism in cellular systems. 
Phosphorylation of proteins can yield a range of changes from subcellular localization, 
signal transduction, and modifications in stability and activity [22]. Several labs have 
dedicated years of study to the role of phosphorylation and the probable sites utilized in 
regulating E 1 activities. Earlier studies have utilized various mutants of the E 1 protein to 
elicit which residues of the protein must be phosphorylated for functional replication [2, 
3, 4, 25, 33]. Substitution mutation of the bovine papillomavirus El protein at threonine 
102 did not seem to significantly modify replication [4], but other mutants, such as serine 
48 and serine 584, had significantly reduced or eliminated replication of the viral genome 
and were hypothesized to be possible phosphorylation sites of an activating nature [2, 
25]. Yet, not all modification of suspected phospho-resides indicated an inhibitory 
activity on replication; alteration of residues serine 90 and serine 109 actually lead to an 
increase in replication activity [3, 33]. These studies provide support for the differential 
effects of certain kinases, but are limited in that site specific assays can only determine 
that site's activity, and not the cumulative action of phosphorylation of all targets of a 
particular kinase. Experimental modification of CDK within an in vitro system seemed to 
suggest that some level ofEl dependency exists on the kinase, but site specificity was not 
determined [26]. Recent mass spectrometric analysis of the El protein revealed a clear 
map of major El protein phosphorylation sites. This data revealed five new 
phosphoamino acid residues and confirmed two known sites [17]. Adding these sites to 
other previously established phosphorylation sites brings the total number of known 
phospho-regulation residues on the El protein to ten. Eight of the ten phosphorylation 
sites are within the amino terminal domain, the region of least conserved sequence 
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(Figure 1 ). While overall the region varies between viral strains, the phospho-residues 
themselves are highly conserved. The positioning of these regulatory sites in this domain 
follows logically in that the necessary regulatory mechanisms should be extremely 
specific to the host environment. Which kinases are responsible for modifying these sites, 
as well as their subsequent pathways, are still unclear. 
The cyclic dependency of replication lead to the initial hypothesis that mitogen 
activated protein kinases (MAPK) and protein kinase A (PKA) are the phosphate donors 
[8], however recent experimental analysis does not seem to indicate that MAPK plays a 
significant role in phosphorylation. PKC, CDK, and CK2, all have been demonstrated to 
phorphorylate the E 1 protein in vitro [21, 23, 26]. Of those sites identified by mass 
spectrometric (MS) analysis, five were found to be of the consensus of CK2 target 
substrates, one of CDK, and one of DNAPK, based upon computer prediction algorithms 
[ 1 7]. Those sites not confirmed by MS analysis, yet verified by other studies, include an 
additional site in the consensus for CDK and two sites ofPKC [3, 4, 33]. Such 
predictions seem intuitive given that those kinases which are known to effect cell cycle 
progression and/or DNA modification are the most likely candidates of site 
phosphorylation, taking in account E1 's role in viral replication. 
Protein kinase C (PKC) is a family of isozymes, which are typically activated via 
receptor binding of hormones, growth factors, and signal transduction agents [15, 16]. 
Some forms of the kinase require calcium and/or phospholipids to stimulate activity. 
PKC has been shown to be necessary for optimal efficiency in production of viral 
progeny and upregulation of late gene expression in human papillomavirus [27, 41]. 
Inhibition of PKC signal transduction pathways has known effects on tumor suppression 
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and inhibition ofrapid cell proliferation [15, 16], and is of key interest to this study, since 
the kinase is known to play a key role in epidem1al differentiation [3, 40]. PKC substrates 
are typically serine/threonine residues with upstream or downstream basic residues, 
particularly arginine [27]. 
Cyclin dependent kinases (CDK) are a group ofkinases largely responsible for 
proper cell cycle progression, specifically at the G liS and 02/M phase boundaries [21-
23, 26]. CDK has been demonstrated to have effects upon the nuclear export sequences 
(NES) and nuclear localization sequences (NLS) of human papillomavirus E1 [21], 
however its effects upon the conserved localization domain in BPV E1 has not been 
definitively assayed [7]. Target consensus sequence for CDK phosphorylated residues are 
comprised of serine or threonine amino acids followed immediately by a proline [21, 26]. 
Casein kinase II (CK2);like all ofthe kinases included in this study is a type of 
serine/threonine kinase. CK2 functions are much more multi-faceted than most other 
kinases studied [20]. The consensus sequence for all CK2 targets is dependent upon 
acidic residues, like glutamate or aspartate, downstream from the phospho-residue [ 18]. 
Its activities range from signal transduction, growth control, cell shape, and even spindle 
formation. CK2 has been found in almost all tissues of all eukaryotes, and is ubiquitous 
in its intracellular distribution [18-20]. High amounts ofCK2 are found in cells exhibiting 
elevated activity levels, especially those which are rapidly proliferating, which strongly 
suggests a supportive role in replication. This enzyme is of particular interest in that it 
expresses constitutive activity, which is optimal for viral replication [18, 20]. 
DNAPK is the least studied kinase used in this analysis, but a few of its activities 
have been published. DNAPK has been shown to be activated by DNA double strand 
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breaks, aneuploidy, or detectable genome abnormality that then phosphorylates the p53 
protein. This phosphorylation activates the well known tumor suppressor protein, which 
subsequently binds to and prevents any replication of the damaged DNA [29]. The kinase 
also has been demonstrated to interact with a variety of transcription factors including 
Ku70, cJun, cFos, Spl, cMyc, and TFIID, and lead to the dissociation ofRPA complex 
[29, 36]. The target phospho-residues ofDNAPK must be closely followed by a 
glutamine residue [29]. Of particular interest to this study is the kinase's reported 
interaction with epidermal growth factor receptor, where the receptor's expression was 
decreased following inhibition ofDNAPK [37]. 
This study serves to illuminate the overall effects of the predicted kinases on viral 
replication. Chemical manipulation of PKC, CDK, CK2, and DNAPK will provide 
details into the respective impact of the specific phosphorylation of the El protein by 
each kinase upon the virus. Whether the inhibitors and/or activators of the kinases lead to 
reduction or addition of detectable viral DNA should give clear indication of the specific 
role of the kinases in viral replication. Alteration ofkinase function yields no effect, 
increase, or decrease of the concentration of viral DNA, as detected by autoradiographic 
film of DNA extracted from infected cells. 
~1ATERIALS AND ~/IETHODS 
Cellular Maintenance and Transfection. Cl27 cells (murine fibroblast) were 
maintained at 3TC with 5% C02 in Dulbecco's Modified Eagle's Medium (DMEM) and 
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10% FBS supplemented with 1 OOiu/mL penicillin and 1 OOmg/mL streptomycin before 
harvest at late log phase. Cells were washed with PBS, and removed from plates by 
addition of 1mL of 0.25% trypsin/ 2mM EDTA, followed by rocking for 5 minutes. Cells 
were transfened to a sterile 50mL Falcon tube containing 5mL of 5mM BES buffered 
complete DMEM. The cell solution was kept on ice prior to counting. Cells were spun 
out of media at 5000 X g for 10 minutes and then resuspended in complete media/BES 
mixture to yield a concentration of 20 million cells/mL. BPV viral genome DNA was 
released from the pML vector via digestion with BamBI (Takara) and 1f.1g of DNA was 
added to eletroporation cuvettes containing 0.1X TE (lmM Tris, 0.1mM EDTA). 
Sheared, denatured salmon spem1 was included as a carrier to final concentration of 50f.lg 
total (200f.1g/mL carrier in cell suspension). Approximately 5 million cells (0.25mL C127 
cell suspension) were added to the DNA containing cuvette and the mixture was shocked 
at 250V and 975f.1F. The samples were incubated at room temperature for 10 minutes and 
each sample was transfened to a 15mL tube containing 1 OmL complete DMEM/BES 
mixture. Cells were pelleted at 750 X g for 10 minutes, resuspended in 8mL complete 
DMEM, and distributed on 8, 10cm diameter plates. 
Focus Assay and Transformed Cell Removal. C127 cells that have successfully 
been transformed with an extrachromosomal episome of BPV DNA produce visible foci 
after 2-3 weeks. During this time cells are kept at 3 7°C with 5% C02 and media replaced 
twice weekly. After transformation, foci were marked on the plate, media removed, and 
plates washed with PBS. A sterile 3mm disk of filter paper, presoaked in 1X trypsin 
solution, was placed on each distinct focus for 1 minute. Each filter disk was then placed 
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in 3.5cm diameter plate, onto which complete DMEM was then added. Cells were 
maintained under the same conditions as previously described until they reached 
approximately 50% confluence. At this time cells were transferred to a 1 Ocm diameter 
plate and either immediately used or stored in liquid nitrogen. 
Cell Culture and Chemical Modification. Transformed cells were sustained as a 
monolayer culture in complete DMEM at 37°C with 5% C02 and were passaged to a 1:20 
dilution at subconfluence into 1 Ocm diameter plates. Two sets of samples for each kinase 
experiment were maintained, and a third for the PKC kinase trials to access the effects of 
the activator. The first set of plates, including one plate for times zero, 48, 96, and 144 
hours (0, 2, 4, and 6 days, respectively), contained only those cells not exposed to 
chemical modifiers. These cells grown in complete DMEM and a small volume of 
DMSO (no more than 50f..LL per plate in any trial) served as a control group, where the 
volume of DMSO was equivalent to the volume of the chemicals in the experimental 
groups. Time point plates represented the length of time that the transformed cells remain 
exposed to the chemical modifiers. A second set was maintained as described above, with 
the addition of 5X IC50 of an inhibitor to a specific enzyme. Kinases of interest and their 
respective inhibitors are shown below: 
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Table 1. Summary of all kinases assayed in this study and the specific chemicals used to 
inhibit their activity. 
Kinase Chemical Inhibitor 
PKC Bisindolylmaleimide [BIM] 
CDK Roscovitine 
CK2 2-Dimethylamino-4,5,6, 7 -tetrabromo-1 H-benzimidazole [DMAT] 
DNAPK 4,5-Dimethyl-2-nitrobenzaldehyde [DMNB] 
All inhibitors used are purchased from Calbiochem and reported as highly selective to 
their respective kinases and cell penneable. The third set of plates for the PKC trials was 
maintained under equivalent conditions, with the addition of 1 OJ.LL of 1 OJ.1M kinase 
activator, tetradecanoyl phorbol acetate (TP A; Calbiochem). Appropriate concentrations 
of chemical modifiers were determined from Calbiochemliterature. 
DNA extraction. The cells were maintained as described above until their relative 
extraction time points were reached (time points were chosen to allow significant time for 
differential viral DNA accumulation). Media was aspirated from the plates and the plates 
were then washed with PBS. Cells were lysed by addition of 800J.1L HIRT buffer (lOmM 
Tris pH 7.8, 10mM EDTA, 0.6% SDS), rocked for approximately 5 minutes, and the 
lysate placed in microfuge tubes. 200J.1L of 5M NaCl was then added to the suspension. 
The tubes were iced for 20 minutes and subsequently centrifuged at 13,500 X g for 20 
minutes at 4°C (All later centrifugation also performed at 4°C). Supernant was 
transferred to a clean tube and 800J.1L of phenol/chlorofmm mixture ( 1:1) added. 
Following thorough vortexing, the tubes were then centrifuged at 13,500 X g for 7 
19 
minutes. The top aqueous layer was removed, added to 800JlL chlorofom1, vortexed, and 
centrifuged briefly at 13,500 X g. 700JlL of the aqueous layer was removed and added to 
42~tL 5M NaCl and 665J..LL isopropanol for storage at 4°C until all time points were 
collected. 
Digest of Extraction Samples. Once all the time points of each kinase trial were 
collected, the samples were centrifuged at 13,500 X g for 10 minutes, the supemant 
aspirated, and the pellet washed with ice cold 70% ethanol. The pellet was air-dried 
before being resuspended in 1 OJ..LL of 20JlglmL RN ase and held at 65°C for 20 minutes. 
The suspension was allowed to cool at room temperature and added to 2.5JlL of lOX H 
Eco buffer (Takara), l2JlL ofDI H20, and 0.5JlL ofEco Rl enzyme (Takara). The 
mixture was digested overnight at 37°C. 
Electrophoresis and Southern Blotting. 5JlL of loading dye was added to each 
digested sample and the mixture was then separated via standard 0.8% agarose gel 
electrophoresis, followed by ethium bromide staining. Each gel was photographed to 
ensure that lanes contained DNA and for later comparison. Agarose gels were soaked in 
Southern Blot denaturation solution (1.5M NaCl, 0.5M NaOH) for 15 minutes and then 
resoaked for an additional 20 minutes to ensure single stranded DNA. DNA from agarose 
gels was transferred to nitrocellulose membranes in lOX SSC solvent (1.5M NaCl, 0.15M 
Na citrate). The transfer proceeded for 12-24 hours and the membrane was then 
autocross-linked via UV Stratalinker (Stratagene). 
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Hybridization and Autoradiography. A radio-probe was constructed by random-p1imed 
synthesis according to manufacture's instructions (Promega) from the isolated DNA of 
the BPV genome and P32 (dCTP). Before hybridization, the Southern blot membranes 
were washed in 2X SSC and placed in hybridization flasks with 7mL Rapid Hyb-buffer 
(Amersham Biosciences). The flasks were placed in a hybridization oven at 55°C for 20 
minutes and then 65°C for 30 minutes. The constructed probe was brought to a boil and 
quick chilled before being poured into the hybridization flasks. Flasks were kept in the 
oven at 65°C for 2 hours, followed by subsequent washes of the membrane to eliminate 
background radioactivity. The radiolabeled membranes were sealed in saran wrap and 
placed on X-ray film in an autoradiography cassette. Exposed film was removed from the 
cassette and developed according to manufacture's instructions (Kodak). 
Neutral Red Viability Assay. Viability of control and chemically treated samples were 
assayed by neutral red uptake (NR) of the transformed cells at various time points. 
BPV/Cl27 cells were maintained as previously described until NR assay time point was 
reached. One plate of each sample set represented times 0, 72, and 166 hours of exposure 
to the respective kinase inhibitor. As described previously, control samples were those 
plates that contained only DMSO dilutent, in place of an equivalent amount of chemical 
modifiers. At time points, media was removed from sample plates, and the plates then 
washed with PBS. A mixture of 1.0% Neutral Red dye (Life Technologies) in complete 
DMEM was added to the cell cultures and returned to incubator at 37°C with 5% C02 for 
an additional 4 hours. After initial observation, cells were removed from plates by 
addition of lmL of trypsin, followed by rocking for 5 minutes. A portion of the 
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suspension was then placed on a standard hemocytometer where overall cell number and 
cell viability, assessed by neutral red uptake, was dete1mined. Total cell number was 
counted on the four comer grids of the hemocytometer, with two suspension aliquots 
counted from each time point plate of control and inhibited samples. From these counts, 
average number of cells per mL of each time point plate was detennined. Number of 
total viable cells was detem1ined by counting of those cells which had clearly taken in the 
neutral red dye. Percent viability of each plate was then calculated by dividing the 
number of viable cells by the total number of cells observed. 
RESULTS 
Mass spectrometric and mutant analysis has provided a map of the major 
phosphorylation sites of the bovine papillomavirus' E1 protein (Figure 1). Eight serine 
and two threonine residues were determined to be phosphorylated. By computer 
algorithms and manual sequence analysis of these phosphorylation sites, those kinases 
that are the most probable donators of the phosphate groups were predicted [3, 4, 17, 33]. 
A composite summary of the known phospho-residues and their predicted kinases are 
shown in Table 1. A comprehensive analysis of enzyme impact upon viral DNA 
eplication of the papillomavirus was performed in order to gain insight into the relative 
regulatory activity of these kinases. Cellular kinases PKC, CDK, CK2, and DNAPK were 
chemically inhibited and/or activated, and Southern blotting of DNA extracts supplied 
directly observable results of each kinase's effect on viral DNA abundance. Manipulation 
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of the kinases could either yield stimulatory or inhibitory effects upon viral DNA 
replication. Following cellular exposure to kinase inhibitors, viral DNA should be 
detected at minimal concentrations or not all at, if the kinase has a stimulatory effect 
upon El in vivo. Conversely, assuming a kinase exhibits an inhibitory effect upon El, 
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Figure 1. Positional phosphate map and functional domains of the BPV El protein. The 
605 amino acid protein is represented on the lower horizontal line. The position of each 
of the phosphorylated amino acids is shown below the line. Functional domains in most 
cases were determined by deletion mutagenesis analysis as described in [7] and 
references therein. Modified from figure in [17]. 
and so overall viral replication, the sample set containing the kinase inhibitor will yield 
increased viral DNA on the southern blot. If the kinase only has a minimal regulatory 
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phosphorylation role, or if the prediction was inconect and the kinase does not play a part 
in regulation of the E 1 protein, manipulation of the kinase would exhibit no effect at all. 
Table 2. Composite of all identified phosphorylation sites on the bovine papillomavirus 
El protein. Included in the table are the locations of each specific phospho-residue in the 
sequence and the kinase that is most likely the phosphate donating enzyme for the site. 
Identified Phos. Sites & Kinases 
Residue Kinase 
Serine 48 CK2 
Serine 90 PKC 
Serine 94 CK2 
Serine 95 CK2 
Serine 100 CK2 
Threonine 1 02 CDK 
Serine 109 PKC 
Threonine 126 CDK 
Serine 305 DNAPK 
Serine 584 CK2 
Protein Kinase C (PKC) Analysis. Residues serine 90 and serine 109 which are 
included in the phosphorylation site map (Figure 1) were not determined from mass 
spectrometry, but were confirmed by other studies, in which mutation analysis of the 
residues each yielded a significant change replication status [33 and 3, respectively]. PKC 
was the kinase determined to target both residues via manual sequence analysis and in 
vitro phosphorylation of wild-type and mutant enzyme. 
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A. 
B. 
Predicted Kinase Phosphorylation Sites 
Residue Sequence Meth Pred 
Ser90 LKRKVLG S SONSSGS Mutant Analysis 
Ser109 TPVKRRK S GAKRRLF Mutant Analysis 
Figure 2. Regulatory impact of PKC phosphmylation oftarget residues ofE1. (A) 
Autoradiographic film of Southern blot containing DNA extracted from BPV transformed 
Cl27 monolayer is shown. Included on film are lanes containing isolated BPV-1 genome 
for use as a marker (M), extracts from control samples (DO-D6), extracts from PKC 
inhibited samples (I0-16), and extracts from samples exposed to PKC activator (AO-A6). 
All sample sets contain extracts taken at day 0 (before exposure to chemical modifiers), 
day 2, day 4, and day 6. Major visible bands represent the viral genome (Vg) at 
approximately 8kbp and a slower moving band of either viral DNA that has become 
integrated with cellular DNA or uncut viral genome (Int). (B) Two phosphorylation sites 
are predicted targets for PKC, namely serine 90 and serine 109. The sunounding 
sequence of the phospho-amino acid and method originally used to predict the residue as 
such a site are included in the table. 
The effect ofPKC phosphorylation upon the regulation of the El protein and its 
~ubsequent effects on viral DNA replication are directly observable on the 
25 
autoradiographic film (Fig. 2A). To verify that the radioactive probe of the viral genome 
successfully and specifically hybridized to the viral DNA extracted from the Cl27 
monolayer and not to the cellular DNA, a control lane of isolated BPV -1 genome was 
included in all assays of each kinase. The control marker used was the same genome 
utilized in C127 transformation, which was comprised only ofBPV DNA that was 
released from the storage vector pML by Bam HI digestion. As expected, the marker 
traveled as a distinct, single band and migrated to a point of approximately 8kbp on 
agarose gel electrophoresis (data not shown). Viral DNA ·replicated in vivo should also 
migrate to a similar location following electrophoresis, and so intact non-integrated viral 
genome will be visible in a band parallel to the marker band. To clearly view this band on 
the autoradiographic film the marker concentration must be within the same order of 
magnitude as the replicated viral DNA, so the marker is not visible on every film. 
However, aligning the film with the picture of the ethium bromide stained agarose gel 
allows each band's relative size and infelTed composition to be detem1ined where 
necessary. All bands labeled as V g were dete1mined to be 8kbp. 
The DMSO control samples (Fig. 2A DO-D6) showed a clear increase in viral 
DNA load over the time course of the experiment, indicating continual viral replication as 
the cells divide. DNA concentrations on day zero and day two were not enough to be 
detected on the film. A single band, representing the replicated viral genome, is present 
beginning at day four (D4). By day six the band has increased in intensity enough to 
indicate at least a doubling in concentration of viral DNA. Two bands, each slower 
moving than the isolated viral genome are also present at D6. While cellular DNA alone 
should not hybridize with the radioactive probe, and therefore not be visible as a band on 
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the autoradiographic film, cellular DNA that has acquired the viral genome would be 
visible. Although the viral genome normally exists as an extrachromosomal episome, the 
observation of integrated DNA is not unheard of [34, 35], but it is not ideal for this study. 
These heavier bands could altematively represent a portion of the viral DNA that was not 
cut by the restriction enzyme during digestion. The intact stmcture of the genome would 
cause it to migrate slower during electrophoresis. 
Lanes labeled as I0-16 contain DNA extracted from the BPV/C127 cells that had 
been exposed to the PKC inhibitor, Bisindolylmaleimide (BMI), which acts competitively 
for the ATP-binding site of the kinase. There is no distinct BPV DNA banding present at 
any time during the course of the trial in these inhibited samples. This does not indicate 
that no viral DNA is present, but instead signifies that the DNA concentration never 
accumulated to detectable levels·. When compared to the control extracts (DO-D6) the 
significant difference in relative abundance of replicated viral DNA between normal and 
inhibited PKC conditions is obvious. Due to the complete absence of detectable viral 
DNA in the inhibited trials for PKC there was some concem that the DNA extraction had 
somehow failed, yet the IO-I6lanes in ethium bromide stained agarose gel clearly 
contained DNA (data not shown). It seems clear that inhibition of the PKC enzyme has 
an effect upon viral replication, and so implicates PKC as a regulatory kinase of the E 1 
protein. 
The remaining four lanes (AO-A6) hold DNA samples from cells maintained in 
media containing a general PKC activator, tissue plasminogen activator (TPA). Results 
appeared very similar to those in the control samples (DO-D6). Lane AO and A2 appear to 
contain no detectable bands of the viral DNA. At day four in the trial viral DNA is at 
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detectable levels, as seen in lane A4. It contains a band oflow intensity, which is barely 
visible on the film at 8kbp, identifying it as intact viral genome. This band is of 
considerably lower concentration than the band present at D4. Bands present in lane A6 
are comparable with those seen in D6. The band of highest intensity, and so highest 
concentration, is at a migratory distance consistent with that of the viral genome. Just as 
in D6, A6 also contains two bands seen above the intact genome, representative of 
integrated DNA or uncut viral genome. Although the concentration of replicated viral 
DNA in A4 was lower than that in D4, the other extraction samples, particularly day 6, 
are similar enough not to label the activator exposed samples as possessing a significantly 
different amount of viral DNA. From this data it does not appear that stimulating PKC 
via TPA yields a change in viral replication and so does not alter the regulatory 
phosphorylation of the E1 protein. These findings do not discount PKC as a regulatory 
kinase, but may imply that there are limitations to the regulatory activity. 
Cyclin-Dependent Kinase (CDK) Analysis. There are three identified potential target 
residues for cyclin dependent kinase (CDK) on the bovine papillomavirus' E1 protein 
(Fig. 3B), and two of these sites are found near E1 's nuclear localization signal (T 102 
and T126, Fig. 1). Threonine 102 was identified as a phosphorylation residue by prior 
mutation analysis with CDK as its most likely kinase, based upon manual sequence 
analysis and enzyme assay of the mutant E 1 protein [ 4]. Although mutation of the residue 
did not reveal significant changes in viral replication, the residue could still have a 
regulatory status in latent replication or exhibit only transient phosphotylation. Threonine 
126 was recognized as a phosphorylation site by mass spectrometry. CDK was predicted 
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as a potential kinase for the site by computer algorithm [17]. Serine 283 is also a 
predicted target for CDK phosphorylation based on sequence analysis, but was not 
included in the phosphorylation site map and has yet to be thoroughly assayed. 
A. 
B. 
Predicted Kinase Phosphorylation Sites 
Residue Sequence Meth Pred 
Thr102 NEANRVL T PLQVQGE Mutant Analysis 
Thr126 SGSEASE T PVKRRKS Mass S_2ectrometty 
Ser283 FWFKSSL S PATPKHG Sequence Analysis 
Figure 3. Regulatory impact ofCDK phosphorylation oftm·get residues ofEl. (A) 
Autoradiographic film of Southern blot containing DNA extracted from BPV transformed 
C127 monolayer is shown. Included on film are lanes containing extracts from control 
samples (DO-D6) and extracts from CDK inhibited samples (I0-16). All sample sets 
contain extracts taken at day 0 (before exposure to chemical modifiers), day 2, day 4, and 
day 6. Major visible bands represent the viral genome (Vg) at approximately 8kbp and a 
slower moving band of either viral DNA that has become integrated with cellular DNA or 
uncut viral genome (Int). (B) Threonine 102, threonine 126, and serine 283 are the 
phosphorylation sites which are predicted targets for CDK. The sunounding sequence of 
the phospho-amino acid and method originally used to predict the residue as such a site 
are included in the table. 
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Regulatmy replication activity of CDK was assayed by comparison of a control set of 
sample extracts with an inhibited set of extracts. The autoradiography of these extract 
samples is shown in Figure 3A. Lanes DO-D6 contain the DNA extracted from the 
BPV/Cl27 cells that had been maintained in complete DMEM and a small volume of 
DMSO dilutent to control for the volume of inhibiting chemical added to the inhibited 
set. The presence of viral DNA (V g) is detectable at the first time point extract (DO) and 
accumulates over the course of the experiment, up to day 6 (D6). The band of intact 
ge11ome is clear and distinct on all time points. A single band, heavier than the intact viral 
genome (V g) is present in DO and most likely represents a portion of the viral DNA that 
had integrated with the cellular DNA. There does appear to be a decrease in 
concentration of viral DNA from D4 to D6. While the cellular environment was 
controlled for and consistent with all time plates in all trials, some random differences in 
cell growth and replication between each plate could be anticipated and is the most likely 
explanation for the unaccountable decrease in viral DNA replication from these two time 
points. 
Lanes I0-16 contain the extracts from those plates exposed to the CDK inhibitor, 
Roscovitine, which competitively inhibits the kinase by blocking the ATP-binding 
domain. As with the control samples (DO-D6), the inhibited samples exhibit detectable 
amounts of viral DNA as early as the first time point (IO). It is clear that the amount of 
viral DNA increases over time, with no deviation. Comparison of the control and 
inhibited samples displays the obvious difference in detectable amount of replicated viral 
DNA. Extracted DNA from the CDK inhibited samples shows a consistently and 
significantly lower concentration of viral DNA (V g) than the control samples. This 
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observation implicates a regulatory role for CDK in viral replication. Specifically, from 
the notable decrease in viral DNA present when the kinase is inhibited, it appears that 
under normal conditions in latent replication CDK phosphorylation of the BPV El 
protein serves to stimulate the synthesis of viral DNA. While these results cannot 
definitively confirm or deny that any target residue (T 102, T 126, or S 283) acts as a 
regulatory phosphorylation site, it does provide evidence that CDK targets some residue 
on the E1 protein to increase viral DNA replication. 
Casein Kinase II (CK2) Analysis. The enzyme CK2 has over 300 known substrates 
and is a well-documented viral replication inducer [18], so it was not surprising that CK2 
was the predicted kinase for so many phosphorylation sites (Fig. 4B). To study CK2's 
role in BPV E1 function, cells were treated as previously described with 2-
Dimethylamino-4,5,6, 7 -tetrabromo-1H-benzimidazole (DMAT). Like the autoradiograph 
of the PKC assay, the concentration of replicated viral DNA only reaches detectable 
levels on the film at days four and six (D4-D6 and 14-16 ofFig-4A). The control extracts 
collected at day four (D4) show a clear, distinct band of intact viral genome (V g). D4 also 
contains a small band, lighter than the intact genome at approximately 6kbp (Frag) which 
is most likely a portion of integrated or intact replicated genome that somehow became 
fragmented. D6 has a noticeably higher concentration of viral DNA that is spilt into at 
least three bands. The V g band is very subtle and barely visible on this film, especially 
when compared to the denser band of integrated DNA in the D6 lane just above it. The 
third D6 band is a very small portion of (intact or integrated) viral genome fragment of 
only 2.2kbp. It is unclear at this time what lead to the fragmentation of the control 
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A 
B. 
Predicted Kinase PhosQ_horylation Sites 
Residue Sequence Meth Pred 
Ser48 VESDRYD S QDEDFVD Mass Spectrometry 
Ser94 VLGSSQN S SGSEASE Mass Spectrometry 
Ser95 LGSSQNS S GSEASET Mass Spectrometry 
Ser100 NSSGSEA S ETPVKRR Mass S_gectrometry 
Ser584 LIDEEED S EEDGDSM Mass Spectrometry 
Figure 4. Regulatory impact ofCK2 phosphorylation of target residues ofEl. (A) 
Autoradiographic film of Southern blot containing DNA extracted from BPV transformed 
C127 monolayer is shown. Included on film are lanes containing extracts from control 
samples (DO-D6) and extracts from CK2 inhibited samples (I0-16). All sample sets 
contain extracts taken at day 0 (before exposure to chemical modifiers), day 2, day 4, and 
day 6. Major visible bands represent the viral genome (Vg) at approximately 8kbp, a 
slower moving band of either viral DNA that has become integrated with cellular DNA or 
uncut viral genome (Int), and smaller bands of fragmented viral genome (Frag). (B) 
Serine 48, serine 94, serine 95, serine 100, and serine 584 are the five phosphorylation 
sites which are predicted targets for CK2. The surrounding sequence of the phospho-
amino acid and method originally used to predict each residue as such a site are included 
in the table. 
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samples in this trial, however the film does show the accumulation of viral genome that is 
necessary for the inhibited comparison. 
Casein kinase II (CK2) phosphorylation activity was modified via ATP-
competitive inhibition by 2-Dimethylamino-4,5,6, 7 -tetrabromo-1 H-benzimidazole 
(DMAT). The DNA extracts of those BPV/Cl27 cells exposed to this chemical 
modification are shown in lanes 10-16. Viral DNA is only detectable on lanes 14 and 16 on 
this autoradiographic film. Due to the intense banding of 16, much of the banding in 14 is 
partially occluded, yet two bands can be clearly identified. The band representing the 
intact viral genome (V g) contains a concentration of DNA, which appears very similar to 
that seen in D4. There is also a light band of relatively low concentration viral DNA 
fragment (Frag). The fragmented DNA is approximately the same size as the fragment 
band seen in lane D6. The extracts taken from BPV/C127 cells exposed to DMAT for 
144 hours (D6) had the highest intensity band of any of the bands in any trial. Several 
bands are present in this lane. The concentration of the intact viral genome and integrated 
DNA bands are of great intensity and almost appear as one large band. Lane 16 also 
contains several smaller bands of DNA. Even though there is no great difference between 
D4 and 14, lanes containing extracts from day 6 on the film clearly show an intense 
increase in replicated viral DNA of the inhibited samples over the control samples. As 
intensity ofbanding is based upon concentration of viral DNA present in the extract, it 
appears as though 16 has roughly a four fold increase in concentration of replicated DNA. 
This observation readily categorizes CK2 as a participant in regulatory activity of the 
bovine papillomavirus. Based upon these results, it appears that the specific nature of 
CK2's involvement in regulation is an inhibitory one. Under normal conditions CK2 
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would therefore be expected to phosphorylate BPV's El protein and lead to a decrease in 
the synthesis of the viral DNA during latent viral replication. These results are especially 
encouraging for this study by showing that chemical modification of CK2 results in an 
increase in viral replication. 
DNA Protein Kinase (DNAPK) Analysis. The enzyme DNAPK is the predicted 
phosphorylating agent of only one residue of the bovine papillomaviruses El protein, 
which was detem1ined by mass spectrometry and computer algorithm (Fig. 5B). Serine 
305, one of the two residues near the functional carboxyl terminus of the protein, is the 
only predicted target for DNAPK phosphorylation. The autoradiographic film displaying 
the extracts from the BPV/C127 plates of the DNAPK assay are shown in Figure 5A. As 
with all the previous films, lanes labeled as DO-D6 contain the radio-probed time point 
extracts of the control samples; those samples maintained only in complete DMEM and a 
volume of DMSO equal to that of the chemical inhibitor added to the other samples. 
DNA samples taken two days following the experimental set-up (D2) are the first to 
shown viral DNA which had been synthesized to a detectable concentration. The 
successive time point extractions collected at days 4 and 6 (D4 and D6) show a clearly 
observable progressive increase in concentration. Given the significant increase in band 
intensity of the intact viral genome (V g) between days two and four, it can be asserted 
that the viral DNA concentration, at least, doubled. It is not as clear to assess the 
concentration increase of viral DNA between D4 and D6, due to the extremely dark 
banding ofboth samples. D4 appears to contain an area of radio-labeled DNA just above 
the 8kbp position of the intact viral genome, and while the boundaries of two distinct 
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bands cannot be discemed, it seems apparent that D4 possesses a region of intact viral 
genome close in proximity to a sample of viral DNA that has become integrated with a 
portion of cellular DNA or an uncut portion of intact viral genome (1nt). The clear 
distinction of these areas is further complicated in this film by the curvature in the control 
bands, which is most likely due to an uneven migration of the extract samples during 
electrophoresis. 
The inhibited sample extracts of the DNAPK assay are contained in lanes labeled 
I0-16. These samples were maintained under normal conditions as previously described, 
except for the addition of an 1C50 concentration of 4,5-Dimethoxy-2-nitrobenzaldehyde 
(DMNB), a highly selective competitive inhibitor ofDNAPK's ATP binding site. The 
presence of replicated viral DNA was not detected in the inhibited extracts until 14. The 
lane labeled as 14 possess one distinct band at 8kbp, representing the intact viral genome. 
The relative intensity of the band is just slightly more dramatic than that seen in the V g 
band of the D2 extracts. 16 contains a single band of viral DNA, the intensity ofwhich is 
clearly increased from 14 but not quite the concentration ofD4 or D6. When comparing 
the bands of viral DNA present in the control and inhibited samples, it is clear that viral 
DNA is present at an earlier time point and accumulates to a much higher concentration 
in the control samples than the inhibited ones. Because replication of both sample sets 
unmistakably increased over time, at very different rates, the outcome of the DNAPK 
assay would support prediction of the kinase's function as a regulatory enzyme in 
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A. 
B. 
Predicted Kinase Phosphorylation Site 
Residue Sequence Meth Pred 
Ser305 AQTTLNE S LQTEKFD Mass Spectrometry 
Figure 5. Regulatory impact ofDNAPK phosphorylation of target residues ofEl. (A) 
Autoradiographic film of Southern blot containing DNA extracted from BPV transfom1ed 
C127 monolayer is shown. Included on film are lanes containing extracts from control 
samples (DO-D6) and extracts from CK2 inhibited samples (I0-16). All sample sets 
contain extracts taken at day 0 (before exposure to chemical modifiers), day 2, day 4, and 
day 6. Major visible bands represent the viral genome (Vg) at approximately 8kbp and a 
slower moving band of either viral DNA that has become integrated with cellular DNA or 
uncut viral genome (Int) (B) Serine 305 is currently the only phosphorylation site which 
is predicted target for DNAPK. The surrounding sequence of the phospho-amino acid and 
method originally used to predict the residue as such a site is included in the table. 
replication mechanism. Inhibition ofDNAPK had noticeable effect on the concentration 
of viral DNA synthesized, and taking in to account this decrease in replicative activity; 
DNAPK could specifically be designated as a stimulatory kinase ofEl function. 
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Neutral Red Viability Assay. Under control conditions the BPV/C127 cells 
continuously grow and reach confluence from a 1 :20 passage of monolayer cells in 4-6 
days and exhibit the characteristic fibroblast spindle shape (Fig. 6A, top left). All plates 
were observed via light microscopy before addition of neutral red mixture, to ensure cells 
were consistently proliferating throughout the plates and to survey the cellular 
morphology of each trial's cells. There was no observable difference in visible density or 
cellular shape between the control plates and any of the inhibited samples. All plates 
possessed uniform distribution over the 1 Ocm diameter dishes at each time point and no 
modified morphology was observed for any of the inhibited trials. The top right image in 
figure 6A shows a PKC inhibited plate at day three; this image is representative of all the 
inhibited plates, as there was no difference between them. The similarity seen between 
the plates suggests that no significant changes in cellular maintenance or structure had 
occurred due to the kinase inhibitions. 
Neutral red (NR) dye was used to aid in the assay of the BPV/C127 cells' 
overall health and proliferation. Neutral red uptake is a procedure commonly used to test 
for chemical cyotoxicity, based upon the experimental chemical's effects on cellular 
metabolism. The weakly cationic dye easily passes through the cellular membrane and is 
collected inside lysosome vesicles through a process which is dependent upon intact 
plasma and lysosomal membranes and active metabolism of the cell [38 and 39]. Cells 
which have experienced any damage or cessation in active metabolism will not be able to 
accumulate the bright red dye in the lysosomes, as an active, healthy cell would be able 
to, and so can be readily distinguished. 
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A. 
B. 
Percent Viability of C127 Cells at Times of Chemical Exposure 
DayO Day3 Day6 
Control 100* 99.991 99.977 
CDK 100* 99.989 99.975 
CK2 100* 99.989 99.965 
DNAPK 100* 99.995 99.969 
PKC 100* 99.997 99.967 
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Figure-6. Viability and proliferative effects of chemical kinase modification on 
the BPV/Cl27 cells. (A) Cellular monolayer ofC127 transfected with BPV-1 genome is 
shown in all fields. Top left image is a control sample (Con) of cells and top right is a 
plate of cells post addition of the PKC inhibitor, BMI (PKC). Bottom images are the 
same plates exposed for four hours to lmL neutral red per lOOmL complete DMEM 
mixture before observation (Con NR & PKC NR). All plates were observed through light 
microscope at day 3 of experiment, digital images taken at IOOX magnification. Neutral 
red images were red enhanced for image color contrast. (B) Table includes calculated 
viability of cells taken at days 0, 3, and 6. All numbers reported as percent viable cells 
(number of viable cells/total number of cells observed). Viability was determined by each 
cell's ability to actively uptake the neutral red dye. * - Indicates that no cells were 
determined to be unviable (no non-colored cells seen). (C) Graphic representation of 
hemocytometer cell counts of control and inhibited samples at three different time points 
during experiment. Day zero counts were taken just before addition of chemical dilutent 
or modifier. Counts were also taken midway through (Day 3) and at the end (Day 6) of 
the chemical exposure. 
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The NR uptake assay was conducted as previously described with cell count, 
viability, and overall morphology observed on three separate time points for control and 
all types of inhibited samples. The PKC activator, TPA, was not included in this portion 
of the study due to the chemicals inability to produce any differentially observable effects 
from the control samples. Following each plates four hour exposure to the NR mixture, 
cells were again observed through a light microscope. There was no generally detectable 
difference between NR uptake of the cell plates at any time point. All viable cells that 
successfully accumulated the dye exhibited an expected change in morphology. The cells 
had a more swollen, rounded appearance, and a ring of red dye was seen around the 
nucleus. All plates demonstrated this cellular change indicating consistent uptake of the 
dye between the control and inhibited samples (Figure 6A, bottom left and bottom right 
images), but closer quantitative investigation is necessary to ensure that kinase inhibition 
is not significantly modifying cellular health and proliferation. 
To acquire accurate cell viability and number counts, the cells were removed 
from the plates and a portion of the cellular suspension was placed on a hemocytometer. 
There were two plates used for each time point of each sample set and the counts were 
repeated eight times for each plate to ensure statistical significance. During each count 
total cell number and number of cells that had not accumulated the NR dye to a clearly 
discernable level were determined. Day zero plates did 'not contain a single cell which 
had not observably accumulated the dye (Fig. 6B). This was not surprising given that the 
cells had just recently been passaged and so were at a low density with plenty of fresh 
DMEM and no chemicals had yet been added. Total cell number was calculated for each 
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sample set and the average total cell numbers all fell within 148-152 x 104 cells/mL with 
a standard deviation within each set no more than+/- 18 x 104 cells/mL (Fig. 6C). 
Midway through the maximum time of chemical exposure, day three, cells were 
again assessed for total number and viability. All plates were at approximately 70% 
confluence prior to NR exposure and cellular removal. Average total number of cells 
present varied more than those in day zero, but all averages remained with+/- 17 x 104 
cells/mL of each other, an amount which is statistically insignificant (Fig. 6C). Closer 
observation of the cellular viability showed relatively few cells did not possess a 
detectable level ofNR. There was a slight variation in amount ofNR within the cells; 
however the vast majority of the cells viewed, exhibited the same relative concentration 
ofNR as the cells seen in day zero. Those few cells with only a minimal amount ofNR 
were counted as non-viable. Total number of non-viable cells remained less than .1% of 
the total cells observed (Fig. 6B). 
By day six of chemical exposure, all plates were at or very near absolute 
confluence. The average number of total cells was highest in the control plates, closely 
followed by the DNAPK and CDK inhibited sets. The PKC and CK2 inhibited sample 
sets' average total number of cells were noticeably less than the other three sets, but 
remained within one standard deviation of their averages (Fig. 6C). The variation 
between the inhibited and control trials were not enough to declare any statistically 
significant difference among the assays. While the number of non-viable cells increased 
from the amount counted in day three, approximately 2 x 104 cells/mL, to 10 x 104 
cells/mL, the percent viability assessment of the cells at day six was somewhat 
surprising. Despite the cellular density, lack of fresh media, and exposure to chemical 
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inhibitors for six days, the total number of cells raised enough for the percentage of 
viable cells to stay at around 99.9% for all sample plates, (Fig. 6B). 
The collective results of the NR viability assay and total cell number counts, 
yield excellent support for the results from the viral replication assays. Kinase inhibition 
by the chemical modifiers BMI, Roscovitine, DMAT, and DMNB, do not appear to 
significantly alter cellular health or proliferation of the BPV /C 127 cells. No difference in 
gross cellular structure, cell viability, or cell growth was detem1ined to be considerable 
en"ough to declare that a change had occuned in cellular replication. Had then been a 
great difference in total cell number of any inhibited sample from the control, the 
integrity of the results of that kinase inhibitor's effect on viral replication would be in 
question, but because there was no significant difference in these variables, alteration of 
viral replication most likely resulted from the decrease in kinase phosphorylation of the 
bovine papilloma virus' E 1 protein. 
DISCUSSIO~ 
The results of these experiments provide a clearer picture of differential 
phosphorylation effects and add to the body of known information about regulation, in 
general, by establishing the effects of phosphate addition to the papillomavirus 
replication system. Relying upon chemical modification of specific kinases, this study 
has yielded evidence which assigns a regulatory role in viral replication of the bovine 
papillomavirus to the kinases PKC, CDK, CK2, and DNAPK. By analysis of the 
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concentrations of viral DNA between extracts from control and kinase inhibited 
BPV/Cl27 cells, specific activities were assigned to these kinases. This data in 
conjunction with the lack of impact these chemicals had upon cellular proliferation, 
maintenance, and viability suggests that PKC, CDK, and DNAPK phosphorylation of the 
BPV E1 protein lead to an increase in viral replication activity, while CK2 
phosphorylation of this same protein causes a decrease in viral DNA replication. All 
kinases assayed in this study were predicted based upon manual or computer analyzed 
consensus sequence comparison of the identified phosphoresidues [2-4, 17, 25, 33]. Each 
enzyme has also been reported to have some role in cell cycle regulation and/or DNA 
metabolism, so it is not surprising that the results of this study implicate them as 
regulators of viral replication. This study only accounts for those kinases which regulate 
E 1 during the latent state of infection, when the protein would be present in the 
undifferentiated cellular strata of the host. The kinases and their relative effects do not 
address vegetative replication. 
By predicting the kinases of five newly identified sites and two already 
suspected sites the data gathered from mass spectrometric analysis served as an excellent 
starting point for this study, but not every phospho-residue, and so not every possible 
kinase, was definitively identified. It remains possible that some sites which are only 
rarely or briefly phosphorylated were missed in the analysis [17] and of course the 
kinases which recognize these sites would be overlooked. Therefore, it was of interest to 
this study to include those kinases which, based upon alternative analytic means, are 
predicted to phosphorylate other phospho-residues. Assays of serine 90 and serine 109 
have strongly implicated these residues as phosphorylation sites [3, 33]. This data, 
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together with kinase's function in epidermal differentiation, provided enough support for 
PKC's role as a regulator to include it in the kinase assays. 
Inhibition of PKC in a monolayer of BPV /C 127 cells lead to a dramatic 
decrease in the concentration of viral DNA that was extracted from the cells. This finding 
in addition to the kinase's effects on repressed tumor suppression, rapid cell growth [15, 
16], and a reported role in regulation of epithelial differentiation [3, 40], provides strong 
support for the enzymes stimulatory action in viral replication. The coupling of a 
regulator of skin differentiation status and viral DNA replication into the same kinase 
would serve as a great means for the virus to link its lifecycle with its host replication 
activity. The replication inducing activity of the kinase in this study contrasts with its 
activity observed in earlier studies. Serine 90 and serine 1 09 site specific studies found 
that a serine/alanine mutant of E 1, which was unable to be phosphorylated at ·those 
residues, replicated more efficiently than the wild type E1 [3, 33]. Utilizing a system 
similar to that used in this study, it was reported that the inability of E 1 to be 
phosphorylated by PKC lead to an increase viral replication activity. What lead to the 
dissimilar results of these studies is unclear at this time. However, it is quite possible that 
phosphorylation of one PKC residue versus phosphorylation of two or more causes 
different effects upon replication. It is important to note that the results of this study 
cannot definitively assert that the kinases predicted to target the identified 
phosphorylation sites are indeed acting on these sites. These results serve only as a 
comprehensive analysis of the kinase effects, not the effects of any site specific 
phosphate addition. A degree of overlap does exist between sequence consensuses of the 
kinases, so it remains possible, although unlikely, that the kinases are targeting a site 
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other that those predicted for it or targeting a residue missed in previous assays as a 
phosphorylation site. 
CDK, a major regulator in cell cycle progression, has been shown to 
phosphorylate threonine 102 in vitro; however mutation study of the site, like those 
performed on S 90 and S 109, did not appear to significantly alter viral replication. Yet, 
based upon this study's autoradiographic data, cyclin dependent kinases (CDK) appear to 
donate their phosphate groups in a mechanism which promotes viral DNA replication. At 
this time CDK's other predicted residues, threonine 126 and serine 283 have not been 
analyzed. It may be that T 126 or S 283 site is the key replication regulator and mutation 
would cause a change in viral replication like that seen in this study or that all three sites 
must be phosphorylated to effect replication regulation, but further investigation of this 
site is needed to determine its function. While the E 1 protein of the bovine 
papillomavirus does not appear to express the CDK target domain of nuclear export, as 
the human group does [21], the significant decrease in concentration of viral DNA 
replicated in those cells exposed to the enzyme's inhibitor signifies that CDK 
phosphorylation does have some effect on E1 activity. CDK has been reported as having 
stimulatory and inhibitory functions in replication of the cellular genome [36]. The 
dynamic status of this kinase may suggest that the enzyme differentially acts upon the 
regulatory E1 protein, based upon concentration, cellular activity, or other metabolic 
factor, in which case the results ofthe CDK assay in this study are only one facet of the 
kinase's total activity. 
Several characteristics of the enzyme CK2 made it of great interest to this 
study; including its published effects upon replication of other viruses, high activity in 
45 
proliferating cells, and constitutive nature [18, 20]. This kinase has an incredibly diverse 
group of known targets of both cellular and viral nature with a wide range of function. 
Like CDK, it may be that this enzyme can lead to several different effects and this study 
has only elucidated one of those functions in the virallifecycle. The CK2 assay clearly 
indicates that phosphate addition by this kinase serves as an inhibitory factor in viral 
replication. Of those residues predicted as targets for CK2, only serine 48 and serine 584 
have been specifically analyzed. Mutation assay of the serine 48 residue suggested a 
stimulatory role for CK2 in viral replication, where substitution of the serine amino acid 
for alanine blocked phosphorylation at this site and yielded a dramatic decrease in the 
concentration of viral DNA replicated [25]. The S 584 residue, found in the ATPase 
domain on the carboxyl end of the E1 protein (Fig. 1), was studied by mutation assay and 
results showed a clear reduction in viral replication [ 1]. This kinase activity predicted by 
both mutant studies is opposite what was discovered by this study. However, as 
previously mentioned the mutation analysis experiments only analyze the function of a 
single residue's phosphorylation, while this study looks at the kinases' overall effects. 
The three other residues, S 94, S 95, and S 100, identified as targets for this kinase have 
yet to be studied. Specific study of these other residues may yield more definite 
explanations of this kinase's activity. 
Results of the DNAPK assay provided evidence of the stimulatory action of the 
kinase's function in viral replication of the bovine papillomavirus. Inhibition of the 
kinase lead to a significant decrease in concentration of viral DNA replicated that was 
extracted fi·om the BPV/C127 cells. This activity is not necessarily consistent with the 
lmown tumor suppressive functions ofDNAPK, but is in line with the kinase's described 
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epidermal growth factor receptor activation [29, 37]. Activity of serine 305, a residue in 
the DNA binding domain ofE1 [17], to date, has not specifically been analyzed. 
While the information yielded from the autoradiographic films of the kinase trials 
are encouraging and certainly sheds some light on the respective regulatory roles of the 
kinases studied, this data alone cannot assert that the differential concentrations of viral 
DNA replicated is solely due to the alteration of E 1 protein phosphorylation by those 
kinases. The very nature of the virus lifecycle further complicates this matter. All the 
kinases included in this study are supplied by the host cells, which the virus takes 
advantage of, and obviously the kinases' primary responsibly would be to carry out 
cellular functions. Any modification of these kinases, could hypothetically lead to an 
alteration of those cellular functions, such as; cellular replication, cell cycle progression, 
growth, cellular maintenance, etc. Therefore, if the chemical modifications used in the 
previously described experiments were causing great changes in the health or growth of 
cells exposed to the inhibitors then any changes in concentration of viral DNA would 
simply be an artifact of that change, and not due to changes in kinase regulation of the E 1 
protein. In other words, reduction in cellular replication, growth, and overall health, 
would directly lead to reduction of viral replication, which is so highly dependent upon 
the cellular machinery. To support any results derived from the replication assay 
experiments, any effects on cellular metabolism must be accounted for. The lack of 
impact upon overall cellular health and viability as assessed by the neutral red assay 
strongly dissociates the differential DNA abundance between the control and treated 
samples from a simple corruption of cellular activity. Instead, such results illustrate that 
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any differences between the relative viral DNA amounts are due to the modification in 
activity of the kinases and their effects upon the viral replication system. 
This study utilized a cellular system similar to the native cells in the host 
epithelium. The cellular monolayer of C 127 exhibited exponential growth, like the 
stratum basale layer ofbovine epithelium undergoes during differentiation. Both 
experimental and native systems consist ofectoderm derived mammalian cells and 
possess the same kinases. There may exist some variation in replication activity of these 
ki1iases between the two cells types, but effects are believed to be subtle, given the 
reported consistencies of the enzyme actives between similar cells [15-21, 29]. The BPV 
transformed C127 cell monolayer system used in this study has been employed 
successfully by several other experiments with the papillomavirus [1-5, 33]. Our results 
support a general model for regulation ofEl function and viral DNA replication by the 
cellular kinases of the host organism. 
Of immediate interest would be to utilize this system to gain a comprehensive 
understanding of these kinases effects on viral replication of the human papilloma virus 
(HPV). A phosphorylation site map ofHPV, like that ofBPV seen in figure 1, is not 
available at this time, but given the similarity of human and bovine epithelium and their 
native kinases, it would be reasonable to believe that comparable kinase effects would be 
observed. A clear image of the exact mechanisms by which this virus uses the cellular 
enzymes to regulate the replication of its viral life cycle will aid in the study and possibly 
the treatment of this virus. A virus which has grave effects upon the human population, 
including the approximately 70 strains of which have been attributed as a factor in the 
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development of cervical cancer, the second most common cancer in women worldwide 
[11]. 
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